CCL vs NKTR · P/E 15, rev $12.83B vs rev $21.0M
Carnival Corporation (CCL) versus Nektar Therapeutics (NKTR) — a side-by-side from cached financials, not a winner call.
Carnival Corporation (CCL) is a travel services company listed on US.
Nektar Therapeutics (NKTR) is a biotechnology company listed on US.
Latest reported CCL revenue for 2026-05-31 was $12.83B. Net income was $795.0M. CCL currently screens at market cap $39.74B and trailing P/E 15.3.
Latest reported NKTR revenue for 2026-06-30 was $21.0M. Net income was -$85.5M. Revenue was up 93.3% from 2026-03-31 to 2026-06-30. NKTR currently screens at market cap $307.2M.
CCL currently screens at market cap $39.74B and trailing P/E 15.3. NKTR currently screens at market cap $307.2M.
Not investment advice. Open the CCL and NKTR stock pages for the full models.
Not investment advice.